Publisher
Medical Device Regulatory News and Industry Insights
Overview
The World Health Organization (WHO) has announced a major expansion of its WHO prequalification programme for medical devices. The updated framework widens the scope of quality-assured, safe, and effective health technologies eligible for international procurement, adding essential reproductive health contraceptives, voluntary male circumcision products, and artificial intelligence-driven diagnostic software.
This initiative provides trusted technical guidance for United Nations agencies (such as UNICEF and UNFPA), global donor organizations, and national health authorities—particularly in low- and middle-income countries where local medical device regulatory systems remain developing or constrained.
1. Broader Product Scope: From Contraceptives to Artificial Intelligence
The expanded scope brings several critical health technologies into the central WHO prequalification pathway:
Sexual & Reproductive Health Devices: The assessment and prequalification for male condoms, female condoms, and Intrauterine Devices (IUDs) are transitioning from the United Nations Population Fund (UNFPA) directly into the WHO prequalification framework. This unification ensures standardized global quality control for family planning and STI prevention tools.
Male Circumcision Devices: Previously evaluated under a standalone assessment process, male circumcision devices are now fully integrated into WHO’s main medical device prequalification framework. These devices support standardized Voluntary Medical Male Circumcision (VMMC) programs, which significantly reduce heterosexual HIV transmission risks.
AI-Driven Digital Health Tools (CAD-TB Software): Marking a significant step for digital health regulation, WHO has added Computer-Aided Detection (CAD) software for Tuberculosis (TB) screening. This software utilizes digital chest X-rays and deep-learning AI algorithms to detect presumptive TB cases rapidly, enabling early clinical diagnosis and treatment in high-burden regions.
2. Strengthening Global Access & Regulatory Trust
With an estimated 70% of countries reporting inadequate or weak regulatory frameworks for health products, the WHO prequalification programme acts as a vital quality gatekeeper.
By conducting independent, transparent, and standardized evaluations, WHO ensures that prequalified items meet international performance and safety standards. Inclusion in the WHO prequalified list reduces procurement risks for international buyers and accelerates local regulatory registration in participating member states.
How Operon Strategist Can Help
As WHO broadens its prequalification scope to encompass reproductive health hardware, surgical tools, and AI software, medical device manufacturers seeking global procurement contracts must align their technical dossiers with rigorous international standards. Operon Strategist provides end-to-end regulatory and quality consulting to guide manufacturers through every stage of international prequalification and market access.
Our key services include:
Software as a Medical Device (SaMD) & AI Compliance: Specialized regulatory advisory for digital health tools to ensure full adherence to IEC 62304 software lifecycle standards, clinical validation requirements, and cybersecurity protocols.
ISO 13485 Quality Management System (QMS) Implementation: Designing, implementing, and auditing robust QMS frameworks tailored to meet WHO-GMP expectations and international regulatory requirements.
CDSCO Medical Device Registration & Licensing: Streamlining domestic approvals, import/manufacturing licenses, and device risk classifications under India’s Medical Devices Rules (MDR), 2017.
CE Marking & Technical File Preparation: Compiling comprehensive technical files, Risk Management Documentation (ISO 14971), and Clinical Evaluation Reports (CER) for EU MDR/IVDR compliance and global expansion.
Get Your Medical Device Market-Ready with Expert Regulatory Support
Publisher | Medical Device Regulatory News and Industry Insights
The Operon Strategist Editorial Team publishes news, updates, and insights on medical device regulations, regulatory policy changes, and global healthcare industry developments. The team covers key regulatory frameworks, including CDSCO, US FDA, EU MDR, ISO 13485, and international market access requirements, helping medical device manufacturers and healthcare businesses stay informed about evolving regulatory expectations.
